Fusilev News
Most Popular Fusilev Story
FDA rejects new indication for Spectrum drug
The FDA declined to approve a supplementary marketing application for Spectrum Pharmaceuticals' cancer drug Fusilev. Currently approved for bone cancer, the company was hoping it could expand the Read more...
Latest Headlines
- October 9, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
